Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.

A phase II trial was performed to investigate the efficacy and tolerance of vinorelbine (VNB), 5-fluorouracil (5-FU), l-leucovorin (LLV) and recombinant human granulocyte colony-stimulating factor (G-CSF) in advanced breast cancer. Between August 1994 and October 1996, 53 patients entered this trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kornek, G. V., Haider, K., Kwasny, W., Lang, F., Krauss, G., Hejna, M., Raderer, M., Weinländer, G., Depisch, D., Scheithauer, W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063060/
https://www.ncbi.nlm.nih.gov/pubmed/9744509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063060/
https://www.ncbi.nlm.nih.gov/pubmed/9744509

Ejemplares similares